• Explore /
  • Poster
  • / Results of a phase II study of atezolizumab and bevacizumab in non-clear cell renal cell carcinoma (nccRCC) and clear cell renal cell carcinoma with sarcomatoid differentiation (sccRCC).

Results of a phase II study of atezolizumab and bevacizumab in non-clear cell renal cell carcinoma (nccRCC) and clear cell renal cell carcinoma with sarcomatoid differentiation (sccRCC).

Abstract Poster

Authors

null

Rana R. McKay

Dana-Farber Cancer Institute, Boston, MA

Rana R. McKay , Bradley Alexander McGregor , Kathryn Gray , John A. Steinharter , Meghara K. Walsh , David A. Braun , Abdallah Flaifel , Eliezer VanAllen , Xiao X. Wei , Sabina Signoretti , Lauren Christine Harshman , Ulka N. Vaishampayan , Toni K. Choueiri

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2019 Genitourinary Cancers Symposium

Session Type

Poster Session

Session Title

Poster Session C: Renal Cell Cancer

Track

Renal Cell Cancer

Sub Track

Renal Cell Cancer

Clinical Trial Registration Number

NCT02724878

Citation

J Clin Oncol 37, 2019 (suppl 7S; abstr 548)

DOI

10.1200/JCO.2019.37.7_suppl.548

Abstract #

548

Poster Bd #

D9

Abstract Disclosures

Similar Posters

First Author: Naoki Furuya

First Author: Dale Randall Shepard

First Author: Aaron Scott Mansfield

First Author: Gabriela Liliana Bravo Montenegro